Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Published:2017-03 Issue:3 Volume:28 Page:590-596
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Belin L.,Kamal M.,Mauborgne C.,Plancher C.,Mulot F.,Delord J.-P.,Gonçalves A.,Gavoille C.,Dubot C.,Isambert N.,Campone M.,Trédan O.,Ricci F.,Alt M.,Loirat D.,Sablin M.-P.,Paoletti X.,Servois V.,Le Tourneau C.

Funder

Agence Nationale de le Recherche (Investissements d’avenir) and SiRIC

NGS platform of the Institut Curie

Agence Nationale de le Recherche

Canceropôle Ile-de-France

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/3/590/11203409/mdw666.pdf

Reference12 articles.

1. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial;Le Tourneau;Lancet Oncol,2015

2. Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers;von Hoff;J Clin Oncol,2010

3. Personalized medicine in a phase I clinical trials program: the M. D. Anderson Cancer Center Initiative;Tsimberidou;Clin Cancer Res,2012

4. Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses;Tsimberidou;Clin Cancer Res,2014

5. Molecular screening for cancer treatment optimization (MOSCATO 01): a prospective molecular triage trial—interim results;Hollebecque;J Clin Oncol,2013

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision-guided treatment in high-risk pediatric cancers;Nature Medicine;2024-06-06

2. Precision Medicine in Veterinary Science;Veterinary Clinics of North America: Small Animal Practice;2024-05

3. The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology;ESMO Open;2024-04

4. Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study;Current Oncology;2023-10-11

5. Precision Medicine;Therapeutic Strategies in Veterinary Oncology;2023-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3